GL1X · GenesisL1 explorer

MolNFT v1 · #84715 · protein

Small molecule inhibitors of the ledgf site of HIV type 1 integrase identified by fragment screening and structure based drug design

3ZT4: “Small molecule inhibitors of the ledgf site of HIV type 1 integrase identified by fragment screening and…”. X-ray diffraction, 2 ligands (ZT2, SO4), 7 pockets (best druggability 0.52). MolNFT v1 #84715 on GenesisL1: 3D structure…

PDB
3ZT4
Type
protein
Length
301 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Integrase
EC
2.7.7.-
UniProt
Q76353
Ligands
ZT2, SO4
Pockets
7 · best druggability 0.52

Structure

x-ray diffraction · 2 distinct chains · 53% helix, 20% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AIntegrase (EC 2.7.7.-)protein15152% helix, 20% strandQ76353
BIntegrase (EC 2.7.7.-)protein15055% helix, 21% strandQ76353

Ligands and binding sites

  • ZT2 · 5-[(E)-(2-oxo-2,3-dihydro-1H-inden-1-ylidene)methyl]-1,3-benzodioxole-4-carboxylic acid · ligand · 4 copies · chains A, B
  • SO4 · Sulfate ion · ion · 6 copies · chains A, B
  • ACY · Acetic acid · additive · 2 copies · chains A, B
  • EDO · 1,2-ethanediol · additive · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

7 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11110.520.8224ZT2
21580.510.7927ZT2
31640.500.7721empty
41140.490.7917ZT2
51980.460.7437empty

Interfaces

1 interface between chains.

  • A–B · 1525 Ų buried · 15 hydrogen bonds · protein-protein

Compared structures

  • 3ZT4 · Small molecule inhibitors of the LEDGF site of HIV type 1 integrase identified by… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.